IT
Iron Triangle Partners LP
High-turnover traderSector-focusedQuality / disciplined sizing
Total reported value
$874.7M
Reporting period: 2025-12-31 · Number of holdings: 27
Iron Triangle Partners LP disclosed 27 holdings in its latest 13F filing for the period ending 2025-12-31, with total reported value of $874.7M and a quarterly turnover rate of 128.0%.
Personality snowflake
- Concentration
- 17.91
- Portfolio Stability
- 100
- Momentum/Contrarian
- 79.48
- Sector conviction
- 100
- Diversification
- 54
- Sizing Uniformity
- 95.34
Recent moves
Trim CVS
-45.8% -$25.8M
Add JAZZ
+94.8% $29.9M
Add CRL
+41.7% $33.8M
Add VCYT
+102.1% $24.6M
Trim BTSG
-27.5% -$3.0M
Add DOCS
+226.9% $15.0M
Holdings Map
New buyAddUnchangedTrim
Top 10 holdings by weight
Full holdings list this quarter
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | CRL | Charles River Laboratories | Stock-Healthcare | 8.66% | +2.70% | +41.69% | |
| 2 | ISRG | Intuitive Surgical INC | Stock-Healthcare | 6.12% | +6.12% | NEW | |
| 3 | RGEN | Repligen CORP | Stock-Healthcare | 6.00% | +0.87% | +18.69% | |
| 4 | JAZZ | Jazz Pharmaceuticals plc | Stock-Healthcare | 5.68% | +2.87% | +94.78% | |
| 5 | VCYT | Veracyte INC | Stock-Other | 4.72% | +2.35% | +102.14% | |
| 6 | BSX | Boston Scientific CORP | Stock-Healthcare | 4.59% | +4.59% | NEW | |
| 7 | WAT | Waters CORP | Stock-Healthcare | 4.57% | +4.57% | NEW | |
| 8 | BKD | Brookdale Senior Living INC | Stock-Other | 4.31% | +0.89% | +23.02% | |
| 9 | LLY | Eli Lilly & Co | Stock-Healthcare | 4.31% | -1.07% | -29.28% | |
| 10 | BRKR | Bruker CORP | Stock-Healthcare | 4.28% | +4.28% | NEW | |
| 11 | VRTX | Vertex Pharmaceuticals INC | Stock-Healthcare | 3.99% | +3.99% | NEW | |
| 12 | CVS | Cvs Health CORP | Stock-Healthcare | 3.92% | -4.63% | -45.80% | |
| 13 | FTRE | Fortrea Holdings INC | Stock-Healthcare | 3.92% | +3.92% | NEW | |
| 14 | MMSI | Merit Medical Systems INC | Stock-Healthcare | 3.89% | +3.89% | NEW | |
| 15 | BTSG | Brightspring Health Services | Stock-Other | 3.84% | -1.37% | -27.54% | |
| 16 | DOCS | Doximity Inc-class A | Stock-Healthcare | 3.48% | +1.30% | +226.94% | |
| 17 | TECH | Bio-techne CORP | Stock-Healthcare | 3.14% | +3.14% | NEW | |
| 18 | ATEC | Alphatec Holdings INC | Stock-Other | 3.09% | +3.09% | NEW | |
| 19 | AHCO | Adapthealth CORP | Stock-Other | 2.97% | +0.52% | +35.59% | |
| 20 | NVST | Envista Holdings CORP | Stock-Healthcare | 2.95% | +2.95% | NEW | |
| 21 | UNH | Unitedhealth Group INC | Stock-Healthcare | 2.65% | +2.65% | NEW | |
| 22 | ABT | Abbott Laboratories | Stock-Healthcare | 2.51% | +2.51% | NEW | |
| 23 | IDYA | Ideaya Biosciences INC | Stock-Other | 1.85% | +0.81% | +73.14% | |
| 24 | BHVN | Biohaven Ltd. | Stock-Other | 1.24% | +1.24% | NEW | |
| 25 | XENE | Xenon Pharmaceuticals INC | Stock-Other | 1.20% | +1.20% | NEW | |
| 26 | DNTH | Dianthus Therapeutics INC | Stock-Other | 1.09% | +1.09% | NEW | |
| 27 | MLYS | Mineralys Therapeutics INC | Stock-Other | 1.07% | +1.07% | NEW |
Reported value over time
Sector allocation
Sector allocation over time
Quarterly history
| Period | Holdings | Total value | Stability | Top holdings |
|---|---|---|---|---|
| 2025-12-31 | 27 | $874.7M | 100 | |
| 2025-09-30 | 25 | $703.3M | 100 | |
| 2025-06-30 | 27 | $651.2M | 0 | |
| 2025-03-31 | 27 | $634.4M | 100 | |
| 2024-12-31 | 23 | $908.4M | 0 | |
| 2024-09-30 | 25 | $721.8M | 0 | |
| 2024-06-30 | 26 | $983.7M | 0 | |
| 2024-03-31 | 29 | $976.3M | 0 | |
| 2023-12-31 | 26 | $772.9M | 0 | |
| 2023-09-30 | 23 | $684.2M | 0 | |
| 2023-06-30 | 23 | $748.1M | 0 | |
| 2023-03-31 | 27 | $693.2M | 0 | |
| 2022-12-31 | 26 | $557.8M | 0 | |
| 2022-09-30 | 27 | $572.0M | 0 | |
| 2022-06-30 | 25 | $771.2M | 0 | |
| 2022-03-31 | 28 | $840.7M | 0 | |
| 2021-12-31 | 25 | $717.7M | 0 | |
| 2021-09-30 | 26 | $696.8M | 0 | |
| 2021-06-30 | 26 | $970.8M | 90 | |
| 2021-03-31 | 27 | $786.5M | 74 | |
| 2020-12-31 | 26 | $771.5M | 99 | |
| 2020-09-30 | 25 | $447.5M | 60 | |
| 2020-06-30 | 24 | $397.1M | 84 | |
| 2020-03-31 | 26 | $258.5M | 100 | |
| 2019-12-31 | 23 | $377.3M | 0 |
Holding changes this quarter
Iron Triangle Partners LP's most significant position changes for 2025-12-31: Sold out: Dexcom INC (DXCM); New buy: Intuitive Surgical INC (ISRG); Sold out: Abbvie INC (ABBV); Sold out: Medtronic plc (MDT); New buy: Boston Scientific CORP (BSX).
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | JAZZ | Jazz Pharmaceuticals plc | +2.9% | +94.78% | Add |
| 2 | CRL | Charles River Laboratories | +2.7% | +41.69% | Add |
| 3 | VCYT | Veracyte INC | +2.4% | +102.14% | Add |
| 4 | DOCS | Doximity Inc-class A | +1.3% | +226.94% | Add |
| 5 | BKD | Brookdale Senior Living INC | +0.9% | +23.02% | Add |
| 6 | RGEN | Repligen CORP | +0.9% | +18.69% | Add |
| 7 | IDYA | Ideaya Biosciences INC | +0.8% | +73.14% | Add |
| 8 | AHCO | Adapthealth CORP | +0.5% | +35.59% | Add |
| 9 | LLY | Eli Lilly & Co | -1.1% | -29.28% | Trim |
| 10 | BTSG | Brightspring Health Services | -1.4% | -27.54% | Trim |
| 11 | CVS | Cvs Health CORP | -4.6% | -45.80% | Trim |
| 12 | DXCM | Dexcom INC | — | EXIT | Sold out |
| 13 | ISRG | Intuitive Surgical INC | — | NEW | New buy |
| 14 | ABBV | Abbvie INC | — | EXIT | Sold out |
| 15 | MDT | Medtronic plc | — | EXIT | Sold out |
| 16 | BSX | Boston Scientific CORP | — | NEW | New buy |
| 17 | WAT | Waters CORP | — | NEW | New buy |
| 18 | BRKR | Bruker CORP | — | NEW | New buy |
| 19 | VRTX | Vertex Pharmaceuticals INC | — | NEW | New buy |
| 20 | FTRE | Fortrea Holdings INC | — | NEW | New buy |
| 21 | MMSI | Merit Medical Systems INC | — | NEW | New buy |
| 22 | GKOS | Glaukos CORP | — | EXIT | Sold out |
| 23 | THC | Tenet Healthcare CORP | — | EXIT | Sold out |
| 24 | TECH | Bio-techne CORP | — | NEW | New buy |
| 25 | EXK | Exact Sciences CORP | — | EXIT | Sold out |
| 26 | ADPT | Adaptive Biotechnologies | — | EXIT | Sold out |
| 27 | ATEC | Alphatec Holdings INC | — | NEW | New buy |
| 28 | MDGL | Madrigal Pharmaceuticals INC | — | EXIT | Sold out |
| 29 | NVST | Envista Holdings CORP | — | NEW | New buy |
| 30 | GH | Guardant Health INC | — | EXIT | Sold out |
| 31 | UNH | Unitedhealth Group INC | — | NEW | New buy |
| 32 | ABT | Abbott Laboratories | — | NEW | New buy |
| 33 | CAH | Cardinal Health INC | — | EXIT | Sold out |
| 34 | NBIX | Neurocrine Biosciences INC | — | EXIT | Sold out |
| 35 | WST | West Pharmaceutical Services | — | EXIT | Sold out |
| 36 | AM6 | Amicus Therapeutics INC | — | EXIT | Sold out |
| 37 | BHVN | Biohaven Ltd. | — | NEW | New buy |
| 38 | XENE | Xenon Pharmaceuticals INC | — | NEW | New buy |
| 39 | DNTH | Dianthus Therapeutics INC | — | NEW | New buy |
| 40 | MLYS | Mineralys Therapeutics INC | — | NEW | New buy |
| 41 | ARGX | Argenx Se - Adr | — | EXIT | Sold out |
FAQ
What is Iron Triangle Partners LP and what type of investor is it?
Iron Triangle Partners LP is a investment manager that files SEC Form 13F quarterly, disclosing its U.S. public equity holdings to regulators. As of the most recent reporting period (2025-12-31), the firm manages a tracked equity portfolio valued at approximately $874.7M, spread across 27 disclosed positions.
What are Iron Triangle Partners LP's largest equity positions?
Based on the latest 13F filing, Iron Triangle Partners LP's top holdings by market value are:
1. Charles River Laboratories (CRL) — $75.7M (8.7%)
2. Intuitive Surgical INC (ISRG) — $53.5M (6.1%)
3. Repligen CORP (RGEN) — $52.5M (6.0%)
4. Jazz Pharmaceuticals plc (JAZZ) — $49.7M (5.7%)
5. Veracyte INC (VCYT) — $41.3M (4.7%)
What changes did Iron Triangle Partners LP make in its most recent portfolio filing?
In the latest reported quarter, Iron Triangle Partners LP made 41 notable position adjustments: 16 new positions were initiated, 8 existing holdings were added to, 3 positions were partially reduced, and 14 were completely exited. The largest of these moves: Sold out: Dexcom INC (DXCM); New buy: Intuitive Surgical INC (ISRG); Sold out: Abbvie INC (ABBV); Sold out: Medtronic plc (MDT); New buy: Boston Scientific CORP (BSX)
What sectors does Iron Triangle Partners LP focus on?
Iron Triangle Partners LP is concentrated in the following sectors based on its current disclosed equity portfolio:
• Health Care: 100.0%